SCPS (Scopus BioPharma) Common Stock: $0.04 Mil (As of Jun. 2023)


What is Scopus BioPharma Common Stock?

Scopus BioPharma SCPS Common Stock is $0.04 Mil as of Jun. 2023.

Scopus BioPharma's quarterly common stock increased from Dec. 2022 ($0.02 Mil) to Mar. 2023 ($0.04 Mil) but then stayed the same from Mar. 2023 ($0.04 Mil) to Jun. 2023 ($0.04 Mil).

Scopus BioPharma's annual common stock increased from Dec. 2020 ($0.02 Mil) to Dec. 2021 ($0.02 Mil) but then stayed the same from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.02 Mil).

Scopus BioPharma Common Stock Historical Data

* Premium members only.

The historical data trend for Scopus BioPharma's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Scopus BioPharma Common Stock Chart

Scopus BioPharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Common Stock
Get a 7-Day Free Trial 0.01 0.01 0.02 0.02 0.02

Scopus BioPharma Quarterly Data
Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.02 0.02 0.04 0.04

Scopus BioPharma Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.04 Mil mean?
Scopus BioPharma (SCPS) has a Common Stock of $0.04 Mil as of Jun. 2023. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Scopus BioPharma and its competitors.
Is Scopus BioPharma's Common Stock too high?
Scopus BioPharma's current Common Stock is $0.04 Mil.
How does Scopus BioPharma's Common Stock compare to AMPE and DRMA?
Scopus BioPharma's Common Stock of $0.04 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Scopus BioPharma and its competitors. Scopus BioPharma's current Common Stock is $0.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Scopus BioPharma stock overvalued right now?
Scopus BioPharma (SCPS) has a current Common Stock of $0.04 Mil. The current Common Stock is $0.04 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Scopus BioPharma (SCPS), the current Common Stock is $0.04 Mil as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Scopus BioPharma Business Description

Address 420 Lexington Avenue, Suite 300, New York, NY, USA, 10170
Scopus BioPharma Inc a biotechnology company focused on developing therapeutics targeting the endocannabinoid system. The endocannabinoid system is comprised of chemical compounds, or cannabinoids, that interact with cannabinoid receptors which are located throughout the body. Its product candidate comprises CO-sTiRNA, which is a STAT3 inhibitor gene therapy and MRI-1867.